CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants
Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
Sponsor: Bausch Health Americas, Inc.
Terminated
Principal Investigator and sponsor agreed to termination.
Other terminated trials from Bausch Health Americas, Inc.
- AKN · Phase PHASE3 · Apr 2024
- Irritable Bowel Syndrome · Phase PHASE2 · Nov 2021
- Severe Hepatic Impairment · Phase PHASE4 · Feb 2020
- Crohn's Disease · Phase PHASE3 · Oct 2017
- Crohn's Disease · Phase PHASE3 · Aug 2017
More terminations from Bausch Health Americas, Inc.
This NA trial investigates Diaper Rash and is currently terminated or withdrawn. Bausch Health Americas, Inc. leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2019 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Jun 2019 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Terminated NA
-
Apr 2017 — Mar 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bausch Health Americas, Inc.
- Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .